Article thumbnail

The Role of CT-Based Attenuation Correction and Collimator Blurring Correction in Striatal Spect Quantification

By J. M. Warwick, S. Rubow, M. du Toit, E. Beetge, P. Carey and P. Dupont


Purpose. Striatal single photon emission computed tomography (SPECT) imaging of the dopaminergic system is becoming increasingly used for clinical and research studies. The question about the value of nonuniform attenuation correction has become more relevant with the increasing availability of hybrid SPECT-CT scanners. In this study, the value of nonuniform attenuation correction and correction for collimator blurring were determined using both phantom data and patient data. Methods. SPECT imaging was performed using 7 anthropomorphic phantom measurements, and 14 patient studies using [I-123]-FP-CIT (DATSCAN). SPECT reconstruction was performed using uniform and nonuniform attenuation correction and collimator blurring corrections. Recovery values (phantom data) or average-specific uptake ratios (patient data) for the different reconstructions were compared at similar noise levels. Results. For the phantom data, improved recovery was found with nonuniform attenuation correction and collimator blurring corrections, with further improvement when performed together. However, for patient data the highest average specific uptake ratio was obtained using collimator blurring correction without nonuniform attenuation correction, probably due to subtle SPECT-CT misregistration. Conclusions. This study suggests that an optimal brain SPECT reconstruction (in terms of the lowest bias) in patients would include a correction for collimator blurring and uniform attenuation correction

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2005). A .C o t ,C .F a l c ´ on, C. Crespo et al., “Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction,”
  2. (1977). A method for attenuation correction in radionuclide computed tomography,”
  3. (2001). a nL a e r e ,M .K o o l e ,J .V e r s i j p t ,a n dR .D i e r c k x ,“ N o n -uniform versus uniform attenuation correction in brain perfusion SPET of healthy volunteers,”
  4. (2010). a r c o u r t ,J .B o o i j ,K .T a t s c he ta l . ,“ E A N Mp r o c e d u r e guidelines for brain neurotransmission SPECT using 123Ilabelled dopamine transporter ligands, version 2,”
  5. (1994). Accelerated image reconstruction using ordered subsets of projection data,”
  6. (1999). Effects of scatter and attenuation correction on quantitative analysis of β-CIT
  7. (2002). Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation,”
  8. (2002). European association of nuclear medicine procedure guidelines for brain neurotransmission SPET using 123I-labelled dopamine transporter ligands,”
  9. (2008). Fakhri, “Is absolute quantification of dopaminergic neurotransmission studies with 123IS P E C T ready for clinical use?”
  10. (2002). Hirose,“Renalcystpseudoenhancementwithbeamhardening effect on
  11. (1998). Importance of bone attenuation in brain SPECT quantification,”
  12. (2005). M o r t o n ,M .J .G u y ,C .A .M a r s h a l l ,E .A .C l a r k e
  13. (2006). Model-based compensation for quantitative
  14. (2006). o c h ,P .E .R a d a u
  15. (2003). o r e t ,P .M .K o u l i b a l y ,J .D a r c o u rt ,S .H a p d e y ,a n dI .B u v a t , “Quantitative accuracy of dopaminergic neurotransmission imaging with 123IS
  16. (2000). Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism,”
  17. (2003). Pav´ ıa et al., “Iterative reconstruction with correction of the spatially variant fan-beam collimator response
  18. (2008). Quantification of dopaminergic neurotransmission SPECT studies with 123Ilabelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation,”
  19. (1999). Quantitationofiodine-123-β-CITdopaminereceptoruptake in a phantom model,”
  20. (2004). Quantitative accuracy of serotonergic neurotransmission imaging with high-resolution 123IS
  21. (2010). S.Bullich,A.Cot,J.Gallegoetal.,“Impactofscattercorrection on D2 receptor occupancy measurements using 123I-IBZM SPECT: comparison to C-Raclopride
  22. (1998). Significance of nonuniform attenuation correction in quantitative brain SPECT imaging,”
  23. (2000). Stereotaxic display of brain lesions,”
  24. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Biometrics Research Department,
  25. (2008). Test-retest variabilityandreliabilityof 123I-IBZMSPECTmeasurementof striataldopamineD2 receptoravailabilityinhealthyvolunteers and influence of iterative reconstruction algorithms,”
  26. (2010). The impact of reconstruction method on the quantification of DaTSCAN images,”
  27. (1994). The importance and implementation of accurate 3D compensation methods for quantitative
  28. (2006). The influence of attenuation correction and reconstructiontechniquesonthedetectionofhypo-perfusedlesions
  29. (2007). Z a k n u n ,H .S c h ¨